Jun 2026 (Q2 FY26) — Jul 30, 2026
CareDx Q2 FY26 — Strong Growth, NAVDX Integration, and Pipeline Advancement
Read the full callCareDx (CDNA) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
CareDx earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 132 | +52.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 85.8 | +98.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 111 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$67.08 +4.81% · +$3.08
Performance +365.5% 1Y
1Y: $14.41 on 17 Oct 2025 → $67.08. High $69.85 (5 Oct 2026), low $14.28 (29 Oct 2025).
- Previous close
- $64
- 52-week range
- $14.28 – $69.85
- One year
- +340.74%
Overview
- Symbol
- CDNA
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
CareDx earnings calls (CDNA)
Financials
What the filings say
Net profit, year on year: +1391% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 83 | 87 | 85 | 87 | 100 | 108 | 118 | 132 |
| Operating profit | -14 | 75 | -13 | -11 | -0 | -6 | 1 | 113 |
| Operating margin | −16.6% | 86.3% | −15.8% | −12.8% | −0.3% | −5.6% | 1.0% | 85.8% |
| Other income | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 |
| Profit before tax | -10 | 78 | -10 | -9 | 2 | -4 | 3 | 115 |
| Tax rate | −1.9% | 0.2% | −0.6% | 1.4% | −0.9% | −9.2% | −1.1% | 3.4% |
| Net profit | -11 | 78 | -10 | -9 | 2 | -4 | 3 | 111 |
| EPS ($ per share) | -0.20 | — | -0.19 | -0.16 | 0.03 | — | 0.05 | 2.15 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -312 | -334 | -353 | -383 | -460 | -678 | -626 | -619 |
| Total liabilities | 35 | 53 | 91 | 101 | 112 | 205 | 113 | 110 |
| Fixed assets | 4 | 4 | 11 | 22 | 36 | 35 | 34 | 33 |
| Investments | — | 0 | 90 | 0 | 203 | 153 | 146 | 112 |
| Total assets | 131 | 152 | 369 | 567 | 543 | 467 | 491 | 413 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4 | -3 | 33 | -19 | -25 | -18 | 38 | 42 |
| Cash from investing | -8 | -23 | -100 | 48 | -229 | 40 | -0 | 2 |
| Cash from financing | 50 | -0 | 163 | 186 | -5 | -30 | -6 | -93 |
| Net cash flow | 38 | -26 | 96 | 214 | -258 | -8 | 32 | -49 |
| Capital expenditure | -2 | — | — | — | — | — | — | — |
| Free cash flow | -6 | — | — | — | — | — | — | — |
Insider filings
88 filings between Oct 22, 2025 and Oct 2, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$13.31M
26 sales by 7 insiders
65% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 23
- Award — granted as compensation
- 12
- Option exercise — converted options into shares
- 27
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hanna John Walter JR | — | $7.54M | Jul 16, 2026 |
| Goldberg Michael | — | $2.10M | Aug 4, 2026 |
| Valantine Hannah | — | $1.32M | Jul 16, 2026 |
| Bickerstaff George | — | $925.7K | Aug 5, 2026 |
| COURNOYER CHRISTINE | — | $751.0K | Aug 4, 2026 |
| Novack Jeffrey Adam | — | $452.7K | Aug 5, 2026 |
| TORRES ARTHUR A | — | $214.7K | May 15, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Goldberg Michael Director | Award | 588 | $0 |
| Oct 1, 2026 | Kennedy Keith CFO & COO | Tax withheld | 3,018 | $199.9K |
| Oct 1, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Tax withheld | 997 | $66.0K |
| Oct 1, 2026 | Meng Jessica Chief Commercial Officer | Tax withheld | 2,619 | $173.5K |
| Oct 1, 2026 | Hanna John Walter JR President and CEO | Tax withheld | 8,511 | $563.7K |
| Sep 12, 2026 | Kennedy Keith CFO & COO | Tax withheld | 8,220 | $430.5K |
| Sep 12, 2026 | Meng Jessica Chief Commercial Officer | Tax withheld | 6,688 | $350.3K |
| Aug 5, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 plan | 500 | $23.4K |
| Aug 5, 2026 | Bickerstaff George Director | Sale | 20,000 | $925.7K |
| Aug 5, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Sale 10b5-1 plan | 2,188 | $101.0K |
| Aug 4, 2026 | COURNOYER CHRISTINE Director | Sale 10b5-1 plan | 16,000 | $751.0K |
| Aug 4, 2026 | Goldberg Michael Director | Sale | 44,700 | $2.10M |
| Aug 1, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Tax withheld | 2,872 | $137.4K |
| Jul 16, 2026 | Valantine Hannah Director | Sale 10b5-1 plan | 100 | $3.7K |
| Jul 16, 2026 | Valantine Hannah Director | Option exercise 10b5-1 plan | 7,606 | $156.4K |
| Jul 16, 2026 | Valantine Hannah Director | Sale 10b5-1 plan | 28,679 | $1.04M |
| Jul 16, 2026 | Valantine Hannah Director | Option exercise 10b5-1 plan | 16,048 | $227.7K |
| Jul 16, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 50,000 | $1.81M |
| Jul 16, 2026 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 plan | 118,000 | $967.6K |
| Jul 16, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 68,000 | $2.65M |
| Jul 16, 2026 | Valantine Hannah Director | Option exercise 10b5-1 plan | 5,125 | $40.8K |
| Jul 2, 2026 | Goldberg Michael Director | Award | 1,746 | $0 |
| Jul 1, 2026 | Hanna John Walter JR President and CEO | Tax withheld | 8,511 | $248.9K |
| Jul 1, 2026 | Kennedy Keith CFO & COO | Tax withheld | 2,930 | $85.7K |
| Jul 1, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Tax withheld | 997 | $29.2K |
| Jul 1, 2026 | Meng Jessica Chief Commercial Officer | Tax withheld | 2,411 | $70.5K |
| Jun 29, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 39,900 | $1.17M |
| Jun 29, 2026 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 plan | 39,900 | $327.2K |
| Jun 26, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 100 | $2.9K |
| Jun 26, 2026 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 plan | 100 | $820 |
| Jun 15, 2026 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 plan | 15,676 | $128.5K |
| Jun 15, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 17,683 | $424.9K |
| Jun 15, 2026 | Valantine Hannah Director | Sale 10b5-1 plan | 12,103 | $279.7K |
| Jun 12, 2026 | Goldberg Michael Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 12, 2026 | Cohen Fred E Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 12, 2026 | Bickerstaff George Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 12, 2026 | COURNOYER CHRISTINE Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 12, 2026 | Riggsbee Richard Bryan Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 12, 2026 | Gunasekaran Suresh Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 12, 2026 | Valantine Hannah Director | Award 10b5-1 plan | 9,795 | $0 |
| Jun 11, 2026 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 plan | 13,618 | $111.7K |
| Jun 11, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 21,998 | $528.4K |
| Jun 6, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Tax withheld | 1,292 | $28.4K |
| Jun 4, 2026 | Hanna John Walter JR President and CEO | Option exercise 10b5-1 plan | 706 | $5.8K |
| Jun 4, 2026 | Hanna John Walter JR President and CEO | Sale 10b5-1 plan | 4,835 | $116.0K |
| May 15, 2026 | TORRES ARTHUR A Director | Sale | 6,484 | $129.0K |
| May 14, 2026 | TORRES ARTHUR A Director | Sale | 4,086 | $85.7K |
| May 5, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Sale | 2,688 | $55.6K |
| May 1, 2026 | Novack Jeffrey Adam Secretary and General Counsel | Tax withheld | 2,873 | $61.8K |
| Apr 20, 2026 | Kennedy Keith CFO & COO | Award | 24,134 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for CareDx, Inc.
Free account. Everything above stays public.
Write why you follow CareDx, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading